|
1
|
Sanli O, Dobruch J, Knowles MA, Burger M,
Alemozaffar M, Nielsen ME and Lotan Y: Bladder cancer. Nat Rev Dis
Primers. 3:170222017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen Z, Liu Q, Chen R, Liu Z, Li M, Ling
Q, Wu L, Yang J, Liu X, Wang T, et al: Clinical analysis of small
cell carcinoma of the bladder in Chinese: Nine case reports and
literature reviews. World J Surg Oncol. 15:332017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao L, Sun J, Wang K, Tai S, Hua R, Yu Y,
Fan Y and Huang J: Development of a new recurrence-free survival
prediction nomogram for patients with primary non-muscle-invasive
bladder cancer based on preoperative controlling nutritional status
score. Cancer Manag Res. 13:6473–6487. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Breau RH, Karnes RJ, Farmer SA, Thapa P,
Cagiannos I, Morash C and Frank I: Progression to detrusor muscle
invasion during urothelial carcinoma surveillance is associated
with poor prognosis. BJU Int. 113:900–906. 2014. View Article : Google Scholar
|
|
5
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Medina MA, Oza G, Sharma A, Arriaga LG,
Hernández Hernández JM, Rotello VM and Ramirez JT: Triple-negative
breast cancer: A review of conventional and advanced therapeutic
strategies. Int J Environ Res Public Health. 17:20782020.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Roche J: The epithelial-to-mesenchymal
transition in cancer. Cancers (Basel). 10:522018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mittal V: Epithelial mesenchymal
transition in tumor metastasis. Annu Rev Pathol. 13:395–412. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang T, Song X, Yang Y, Wan X, Alvarez
AA, Sastry N, Feng H, Hu B and Cheng SY: Autophagy and hallmarks of
cancer. Crit Rev Oncog. 23:247–267. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
White E and DiPaola RS: The double-edged
sword of autophagy modulation in cancer. Clin Cancer Res.
15:5308–5316. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin YC, Lin JF, Wen SI, Yang SC, Tsai TF,
Chen HE, Chou KY and Hwang TI: Inhibition of high basal level of
autophagy induces apoptosis in human bladder cancer cells. J Urol.
195:1126–1135. 2016. View Article : Google Scholar
|
|
12
|
Chou KY, Chen PC, Chang AC, Tsai TF, Chen
HE, Ho CY and Hwang TI: Attenuation of chloroquine and
hydroxychloroquine on the invasive potential of bladder cancer
through targeting matrix metalloproteinase 2 expression. Environ
Toxicol. 36:2138–2145. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Quan Y, Lei H, Wahafu W, Liu Y, Ping H and
Zhang X: Inhibition of autophagy enhances the anticancer effect of
enzalutamide on bladder cancer. Biomed Pharmacother.
120:1094902019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
O'Brien J, Hayder H, Zayed Y and Peng C:
Overview of MicroRNA biogenesis, mechanisms of actions, and
circulation. Front Endocrinol (Lausanne). 9:4022018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar :
|
|
16
|
Fu G, Brkić J, Hayder H and Peng C:
MicroRNAs in human placental development and pregnancy
complications. Int J Mol Sci. 14:5519–5544. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar :
|
|
18
|
Hwang TI, Chen PC, Tsai TF, Lin JF, Chou
KY, Ho CY, Chen HE and Chang AC: Hsa-miR-30a-3p overcomes the
acquired protective autophagy of bladder cancer in chemotherapy and
suppresses tumor growth and muscle invasion. Cell Death Dis.
13:3902022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Angelucci F, Cechova K, Valis M, Kuca K,
Zhang B and Hort J: MicroRNAs in Alzheimer's disease: Diagnostic
markers or therapeutic agents? Front Pharmacol. 10:6652019.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang CC, Tseng TT, Liu SC, Lin YY, Law
YY, Hu SL, Wang SW, Tsai CH and Tang CH: S1P increases VEGF
production in osteoblasts and facilitates endothelial progenitor
cell angiogenesis by inhibiting miR-16-5p expression via the
c-Src/FAK signaling pathway in rheumatoid arthritis. Cells.
10:21682021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Çakmak HA and Demir M: MicroRNA and
cardiovascular diseases. Balkan Med J. 37:60–71. 2020.PubMed/NCBI
|
|
22
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar
|
|
23
|
Dalmay T and Edwards DR: MicroRNAs and the
hallmarks of cancer. Oncogene. 25:6170–6175. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chou KY, Chang AC, Tsai TF, Lin YC, Chen
HE, Ho CY, Chen PC and Hwang TI: MicroRNA-34a-5p serves as a tumor
suppressor by regulating the cell motility of bladder cancer cells
through matrix metalloproteinase-2 silencing. Oncol Rep.
45:911–920. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang L, Liao Y and Tang L: MicroRNA-34
family: A potential tumor suppressor and therapeutic candidate in
cancer. J Exp Clin Cancer Res. 38:532019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li WJ, Wang Y, Liu R, Kasinski AL, Shen H,
Slack FJ and Tang DG: MicroRNA-34a: Potent tumor suppressor, cancer
stem cell inhibitor, and potential anticancer therapeutic. Front
Cell Dev Biol. 9:6405872021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen F and Hu SJ: Effect of microRNA-34a
in cell cycle, differentiation, and apoptosis: A review. J Biochem
Mol Toxicol. 26:79–86. 2012. View Article : Google Scholar
|
|
28
|
Wang X, Zhao Y, Lu Q, Fei X, Lu C, Li C
and Chen H: MiR-34a-5p inhibits proliferation, migration, invasion
and epithelial-mesenchymal transition in esophageal squamous cell
carcinoma by targeting LEF1 and inactivation of the Hippo-YAP1/TAZ
signaling pathway. J Cancer. 11:3072–3081. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang S, Li Y, Gao J, Zhang T, Li S, Luo A,
Chen H, Ding F, Wang X and Liu Z: MicroRNA-34 suppresses breast
cancer invasion and metastasis by directly targeting Fra-1.
Oncogene. 32:4294–4303. 2013. View Article : Google Scholar
|
|
30
|
Wu X, Cheng YL, Matthen M, Yoon A,
Schwartz GK, Bala S, Taylor AM and Momen-Heravi F: Down-regulation
of the tumor suppressor miR-34a contributes to head and neck cancer
by up-regulating the MET oncogene and modulating tumor immune
evasion. J Exp Clin Cancer Res. 40:702021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ho CY, Chang AC, Hsu CH, Tsai TF, Lin YC,
Chou KY, Chen HE, Lin JF, Chen PC and Hwang TI: Miconazole induces
protective autophagy in bladder cancer cells. Environ Toxicol.
36:185–193. 2021. View Article : Google Scholar
|
|
32
|
Chuang JY, Chang AC, Chiang IP, Tsai MH
and Tang CH: Apoptosis signal-regulating kinase 1 is involved in
WISP-1-promoted cell motility in human oral squamous cell carcinoma
cells. PLoS One. 8:e780222013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tsai HC, Chang AC, Tsai CH, Huang YL, Gan
L, Chen CK, Liu SC, Huang TY, Fong YC and Tang CH: CCN2 promotes
drug resistance in osteosarcoma by enhancing ABCG2 expression. J
Cell Physiol. 234:9297–9307. 2019. View Article : Google Scholar
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
35
|
Lin JF, Lin YC, Tsai TF, Chen HE, Chou KY
and Hwang TI: Cisplatin induces protective autophagy through
activation of BECN1 in human bladder cancer cells. Drug Des Devel
Ther. 11:1517–1533. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Parzych KR and Klionsky DJ: An overview of
autophagy: Morphology, mechanism, and regulation. Antioxid Redox
Signal. 20:460–473. 2014. View Article : Google Scholar :
|
|
37
|
Lőrincz P and Juhász G:
Autophagosome-lysosome fusion. J Mol Biol. 432:2462–2482. 2020.
View Article : Google Scholar
|
|
38
|
Chang AC, Lien MY, Tsai MH, Hua CH and
Tang CH: WISP-1 promotes epithelial-mesenchymal transition in oral
squamous cell carcinoma cells via the miR-153-3p/Snail axis.
Cancers (Basel). 11:19032019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang C, Dou R, Wei C, Liu K, Shi D, Zhang
C, Liu Q, Wang S and Xiong B: Tumor-derived exosomal
microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM
interaction to facilitate CRC metastasis. Mol Ther. 29:2088–2107.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sun F, Fu H, Liu Q, Tie Y, Zhu J, Xing R,
Sun Z and Zheng X: Downregulation of CCND1 and CDK6 by miR-34a
induces cell cycle arrest. FEBS Lett. 582:1564–1568. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xu Y, Guo B, Liu X and Tao K: miR-34a
inhibits melanoma growth by targeting ZEB1. Aging (Albany NY).
13:15538–15547. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Siemens H, Jackstadt R, Hünten S, Kaller
M, Menssen A, Götz U and Hermeking H: miR-34 and SNAIL form a
double-negative feedback loop to regulate epithelial-mesenchymal
transitions. Cell Cycle. 10:4256–4271. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Imani S, Wei C, Cheng J, Khan MA, Fu S,
Yang L, Tania M, Zhang X, Xiao X, Zhang X and Fu J: MicroRNA-34a
targets epithelial to mesenchymal transition-inducing transcription
factors (EMT-TFs) and inhibits breast cancer cell migration and
invasion. Oncotarget. 8:21362–21379. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tsai TF, Chang AC, Chen PC, Ho CY, Chen
HE, Chou KY and Hwang TI: Autophagy blockade potentiates
cancer-associated immunosuppression through programmed death
ligand-1 upregulation in bladder cancer. J Cell Physiol.
237:3587–3597. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang X, Li J, Dong K, Lin F, Long M,
Ouyang Y, Wei J, Chen X, Weng Y, He T and Zhang H: Tumor suppressor
miR-34a targets PD-L1 and functions as a potential
immunotherapeutic target in acute myeloid leukemia. Cell Signal.
27:443–452. 2015. View Article : Google Scholar
|
|
46
|
Ding ZS, He YH, Deng YS, Peng PX, Wang JF,
Chen X, Zhao PY and Zhou XF: MicroRNA-34a inhibits bladder cancer
cell migration and invasion, and upregulates PTEN expression. Oncol
Lett. 18:5549–5554. 2019.PubMed/NCBI
|
|
47
|
Yan D, Zhou X, Chen X, Hu DN, Dong XD,
Wang J, Lu F, Tu L and Qu J: MicroRNA-34a inhibits uveal melanoma
cell proliferation and migration through downregulation of c-Met.
Invest Ophthalmol Vis Sci. 50:1559–1565. 2009. View Article : Google Scholar
|
|
48
|
Helmy SA, El-Mesery M, El-Karef A, Eissa
LA and El Gayar AM: Chloroquine upregulates TRAIL/TRAILR2
expression and potentiates doxorubicin anti-tumor activity in
thioacetamide-induced hepatocellular carcinoma model. Chem Biol
Interact. 279:84–94. 2018. View Article : Google Scholar
|
|
49
|
Liu X, Sun K, Wang H and Dai Y: Inhibition
of autophagy by chloroquine enhances the antitumor efficacy of
sorafenib in glioblastoma. Cell Mol Neurobiol. 36:1197–1208. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Verbaanderd C, Maes H, Schaaf MB, Sukhatme
VP, Pantziarka P, Sukhatme V, Agostinis P and Bouche G: Repurposing
drugs in oncology (ReDO)-chloroquine and hydroxychloroquine as
anti-cancer agents. Ecancermedicalscience. 11:7812017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sharifi MN, Mowers EE, Drake LE, Collier
C, Chen H, Zamora M, Mui S and Macleod KF: Autophagy promotes focal
adhesion disassembly and cell motility of metastatic tumor cells
through the direct interaction of paxillin with LC3. Cell Rep.
15:1660–1672. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zheng K, He Z, Kitazato K and Wang Y:
Selective autophagy regulates cell cycle in cancer therapy.
Theranostics. 9:104–125. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Liu T, Zhang J, Li K, Deng L and Wang H:
Combination of an autophagy inducer and an autophagy inhibitor: A
smarter strategy emerging in cancer therapy. Front Pharmacol.
11:4082020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Itakura E, Kishi-Itakura C and Mizushima
N: The hairpin-type tail-anchored SNARE syntaxin 17 targets to
autophagosomes for fusion with endosomes/lysosomes. Cell.
151:1256–1269. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Hong DS, Kang YK, Borad M, Sachdev J,
Ejadi S, Lim HY, Brenner AJ, Park K, Lee JL, Kim TY, et al: Phase 1
study of MRX34, a liposomal miR-34a mimic, in patients with
advanced solid tumours. Br J Cancer. 122:1630–1637. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Jacot W, Dalenc F, Lopez-Crapez E,
Chaltiel L, Durigova A, Gros N, Lozano N, Lacaze JL, Pouderoux S,
Gladieff L, et al: PIK3CA mutations early persistence in cell-free
tumor DNA as a negative prognostic factor in metastatic breast
cancer patients treated with hormonal therapy. Breast Cancer Res
Treat. 177:659–667. 2019. View Article : Google Scholar : PubMed/NCBI
|
